The new era of personalised cancer care requires different thinking from pharma companies, according to experts at the ESMO symposium. …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

